Bullous Haemorrhagic Dermatosis: A Benign Rare Cutaneous Complication of Low Molecular Weight Heparin| Chapter 2 | Perspective of Recent Advances in Medical Research Vol. 8

 Enoxaparin-arbitrated bullous hemorrhagic dermatosis (BHD) is a exceptional side effect that happens all along enoxaparin prophylaxis for diversified thromboembolic occurrences. We describe a case of a 74-period-woman accompanying various comorbidities the one grown BHD after taking subcutaneous enoxaparin at a various site. The disease of BHD was rooted by histopathological test. Bullae development evenly vanished after the patient's enoxaparin situation was blocked, and apixaban, a novel oral anticoagulant, was executed. Skin loss, pruritus, maculopapular rash, eczematous rash, and bullous hemorrhagic dermatosis are some of ultimate ordinary cutaneous side effects of enoxaparin. A comparably exceptional and benign reaction of enoxaparin, that is an under-acknowledged consequence of depressed-microscopic-weight heparin, is hemorrhagic bullae dermatosis at a place apart from the presidency site.   Since these cutaneous responses can happen at whatever time, regardless of the event of anticoagulation medicine, careful listening is necessary during heparin presidency.

Author(s) Details:

Arnab Choudhury,
Department of Internal Medicine, All India Institute of Medical Sciences, Rishikesh, India.

Please see the link here: https://stm.bookpi.org/PRAMR-V8/article/view/9336

A Brief Study about Allergic Rhinitis | Chapter 18 | Issues and Developments in Medicine and Medical Research Vol. 7

 The current research gives an overview of Allergic Rhinitis and how to treat it. It's a great resource for rhinology students and physicians that deal with this condition. It teaches them how to examine allergic rhinitis patients in a systematic way, which is quite frequent in most demographics and causes a lot of morbidity. Allergy is a difficult subject to learn in general, and treating individuals with this ailment requires a lot of perseverance. The first step in treating a patient with allergic rhinitis is to get a thorough medical history. Following that, a full assessment and inquiry will be conducted. The general practitioner is the first professional involved in the treatment of allergic rhinitis patients, followed by specialists, particularly otorhinolaryngologists, and finally allied healthcare staff. Nasal blockage, obstruction, or congestion, as well as nasal discharge, are all indications of inflammation of the nose and paranasal sinuses. Facial pain/pressure, as well as a diminution or loss of scent, are common symptoms. Endoscopic signs of nasal polyps, mucopurulent discharge, and mucosal oedema in the middle meatus, as well as CT changes of mucosa within the ostoemeatal complex and sinuses, are seen. Definitions, etiologies, clinical manifestations, diagnosis/prognosis, and therapy of allergic rhinitis are all discussed. The common allergens that cause the condition are examined, as well as the pathophysiology and classification of allergic rhinitis. Different forms of allergy testing are discussed, along with their functions and characteristics. Immunotherapy principles in the treatment of allergic rhinitis are explored in this article. The health repercussions of allergic rhinitis are discussed, as well as their impact on physical quality of life. The main purpose of this presentation is to improve diagnosis accuracy by encouraging appropriate use of ancillary tests including nasoendoscopy, allergy testing, computed tomography, and other comparable procedures, as well as minimising antibiotic use. The treatment strategy is determined on the severity and duration of allergic rhinitis. Allergy avoidance, medicine, allergen immunotherapy, and limited-function surgery are all covered.

Author(S) Details

Debashis Acharya
Primary Health Care Corporation, Govt. of Qatar, Qatar.

View Book:- https://stm.bookpi.org/IDMMR-V7/article/view/5773